Business research

Algorithms

Diffuse Large B-Cell Lymphoma (DLBCL) Pipeline Insight, 2025: Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma, accounting for approximately 25% to 30% of all cases. It typically manifests as rapidly enlarging lymph nodes or masses, which may occur within or outside the lymphatic system. DLBCL originates from abnormal B-cell proliferation, often stemming from